9630997

Source:http://linkedlifedata.com/resource/pubmed/id/9630997

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0041714, umls-concept:C0549178, umls-concept:C0805586, umls-concept:C1301860
pubmed:issue	7
pubmed:dateCreated	1998-7-7
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9604648
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1087-0156
pubmed:author	pubmed-author:GlaserVV
pubmed:issnType	Print
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	811-2
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:9630997-Drug Approval, pubmed-meshheading:9630997-Humans, pubmed-meshheading:9630997-Interferon-beta, pubmed-meshheading:9630997-Multiple Sclerosis, pubmed-meshheading:9630997-Orphan Drug Production, pubmed-meshheading:9630997-United States, pubmed-meshheading:9630997-United States Food and Drug Administration
pubmed:year	1996
pubmed:articleTitle	Berlex continues legal challenge to FDA over MS drug.
pubmed:publicationType	News